Patents by Inventor Stefano Sammicheli

Stefano Sammicheli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD47-CD38 BISPECIFIC ANTIBODIES
    Publication number: 20240150489
    Abstract: Novel bispecific heterodimeric immunoglobulins that target both a component of the human CD47 antigen and human CD38 antigen are provided and in particular those comprising an anti-CD38 heavy chain variable region and a light chain variable region and an anti-CD47 heavy chain variable region and a light chain variable region. The present invention also relates to the use of this novel class of bispecific heterodimeric immunoglobulins to treat autoimmune and proliferative diseases and in particular cancers such as hematologic malignancies and solid tumors.
    Type: Application
    Filed: October 11, 2023
    Publication date: May 9, 2024
    Inventors: Laure BOUCHEZ, Blandine POULEAU, Marie-Agnes DOUCEY, Elie DHEILLY, Stanislas BLEIN, Cian STUTZ, Carole ESTOPPEY, Jeremy LOYAU, Thierry MONNEY, Camille GRANDCLEMENT, Stefano SAMMICHELI
  • CD47-CD38 BISPECIFIC ANTIBODIES
    Publication number: 20240141062
    Abstract: Novel bispecific heterodimeric immunoglobulins that target both a component of the human CD47 antigen and human CD38 antigen are provided and in particular those comprising an anti-CD38 heavy chain variable region and a light chain variable region and an anti-CD47 heavy chain variable region and a light chain variable region. The present invention also relates to the use of this novel class of bispecific heterodimeric immunoglobulins to treat autoimmune and proliferative diseases and in particular cancers such as hematologic malignancies and solid tumors.
    Type: Application
    Filed: October 11, 2023
    Publication date: May 2, 2024
    Inventors: Laure BOUCHEZ, Blandine POULEAU, Marie-Agnes DOUCEY, Elie DHEILLY, Stanislas BLEIN, Cian STUTZ, Carole ESTOPPEY, Jeremy LOYAU, Thierry MONNEY, Camille GRANDCLEMENT, Stefano SAMMICHELI, Cyrille DREYFUS
  • CD47-CD38 BISPECIFIC ANTIBODIES
    Publication number: 20220089767
    Abstract: Novel bispecific heterodimeric immunoglobulins that target both a component of the human CD47 antigen and human CD38 antigen are provided and in particular those comprising an anti-CD38 heavy chain variable region and a light chain variable region and an anti-CD47 heavy chain variable region and a light chain variable region. The present invention also relates to the use of this novel class of bispecific heterodimeric immunoglobulins to treat autoimmune and proliferative diseases and in particular cancers such as hematologic malignancies and solid tumors.
    Type: Application
    Filed: September 17, 2021
    Publication date: March 24, 2022
    Inventors: Laure Bouchez, Blandine Pouleau, Marie-Agnes Doucey, Elie Dheilly, Stanislas Blein, Cian Stutz, Carole Estoppey, Jeremy Loyau, Thierry Monney, Camille Grandclement, Stefano Sammicheli